Sitting Down With

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#News

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

Vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#Videos

Meet The Exhibitor
#AI / data analytics / healthtech / informatics #Antibodies #Cancer research #Career #From the top #Genetics / genomics #Interview #Meet the Researcher #Oncology #Research and development #Sitting Down With #Women in STEM

New podcast: Getting to know key drug discovery leaders

This is the latest episode of the free DDW narrated podcast, titled “Getting to know key drug discovery leaders”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura”… Read More

#News

#Drug development #Drug discovery #Interview #NanoTemper Technologies #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Philipp Baaske, NanoTemper

DDW’s Megan Thomas caught up with Philipp Baaske, Co-Founder & Executive Chairman of NanoTemper Technologies, about biophysical characterisation techniques for complex biologics. Highlights of the Vodcast As drug discovery moves beyond traditional small molecules, biophysical characterisation techniques must evolve to keep pace with the increasing complexity of new drug… Read More

#News

#Drug development #Drug discovery #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Vodcast: Revolutionising preclinical research with AI-powered home cage monitoring

The latest sponsored DDW Sitting Down With vodcast features Michael Ellis, Senior Director of R&D at The Jackson Laboratory (JAX), and Timothy Robertson, CEO of TLR Ventures and Leader of the Digital In Vivo Alliance to introduce their new digital home cage monitoring system, Envision. Both Ellis and… Read More

#Videos

#Animal models #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Watch the latest DDW vodcast

The latest DDW Sitting Down With sponsored vodcast is now available. It features Dr Adriano Flora, Director of Business Development at The Jackson Laboratory (JAX). In this vodcast, he discusses alternatives to non-human primates, the key benefits of this, and what impact will they have on the future of… Read More

#News

#Drug development #Drug discovery #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Vodcast: Dr Adriano Flora, The Jackson Laboratory

The latest sponsored DDW Sitting Down With vodcast features Dr Adriano Flora, Director of Business Development at The Jackson Laboratory (JAX). He discusses alternatives to non-human primates, the key benefits of this, and what impact will they have on the future of drug development. Moreover, he answers questions on… Read More

#Videos

MRI of the brain
#AI / data analytics / healthtech / informatics #epilepsy #Interview #Omics #Sitting Down With

Sitting down with… Stefanie Dedeurwaerdere, UCB

Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role, she is responsible for the development of UCB’s epilepsy discovery strategy, working with researchers to advance understanding of epilepsies while ensuring candidates for a future clinical… Read More

#Exclusive Content #Opinion

Immunity
#Immunity #Neurology #Novartis #Sitting Down With

Sitting down with… Catherine Emond, Novartis  

Catherine Emond is the Head of Immunology and Neuroscience at Novartis UK. She is responsible for driving long-term strategies that can help change the lives of people with challenging immunological and neurological conditions. With over two decades of leadership experience, Emond is known for her broad brand lifecycle management achievements… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Cancer research #Genetics / genomics #Interview #Oncology #Sitting Down With

Sitting down with… Neil Dhawan

Listen to this article on the DDW Podcast: Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company’s approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI). RA: How is Totus Medicines attempting to… Read More

#Cancer Research #Exclusive Content

#Cancer research #Cancer Research Horizons #Interview #Sitting Down With #Sitting Down With podcast

How Cancer Research Horizons is innovating through its academic and industry interface

The latest sponsored DDW Sitting Down With podcast features Steve Wedge, Chief Scientific Officer of Cancer Research Horizons and Mike Waring, Head of Academic Medicinal Chemistry at Cancer Research Horizons. They discuss the work Cancer Research Horizons is conducting at its site in Newcastle University; how Cancer Research… Read More

#Podcasts

#ApconiX #Drug safety #Interview #Sitting Down With #Sitting Down With podcast

How a target safety assessment supports the drug development process

In the latest sponsored DDW Sitting Down With podcast Professor Ruth Roberts, Co-Founder ApconiX, and Claire Sadler, Project Toxicologist, discuss the benefits of carrying out a target safety assessment (TSA) during drug discovery and development whenever a biological target is going to be modulated. The speakers outline… Read More

#Podcasts

#DDW Highlights podcast #In Conversation Series #Narrated podcasts #Sitting Down With

The DDW Podcast: 2022 in review 

As 2022 draws to a close, DDW’s Multimedia Editor and podcast host Megan Thomas rounds up all the free episodes of the DDW podcast that were released. 2022 saw the introduction of the DDW Highlights podcast as well as the In Conversation With… Read More

#Exclusive Content #News

#Drug discovery #Gut microbiome #Sitting Down With

Exploring the microbiome: how it is shaping preclinical research

This is the latest DDW Sitting Down With sponsored podcast, which features Dr John Couse, Vice President of Scientific Services at Taconic Biosciences, who discusses how the microbiome is transforming drug discovery and what this means for pharmaceutical and biotech companies. Couse offers detailed insight into the microbiome and outlines its role… Read More

#Podcasts

#DNA technology #Drug discovery #Podcast #Recombinant DNA #Sitting Down With #Target identification #Target validation

Recombinant DNA technology and its impact on modern drug discovery

The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological. Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and… Read More

#Podcasts